| PERIOD ENDING | 28-Feb-09 | 29-Nov-08 | 6-Sep-08 | 14-Jun-08 | | Total Revenue | 10,820,000 | 10,171,000 | 10,226,000 | 13,347,000 | | Cost of Revenue | 8,341,000 | 7,891,000 | 7,937,000 | 10,282,000 | | | Gross Profit | 2,479,000 | 2,280,000 | 2,289,000 | 3,065,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,269,000 | 1,921,000 | 1,947,000 | 2,609,000 | | Non Recurring | 274,000 | 3,250,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (64,000) | (2,891,000) | 342,000 | 456,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (53,000) | (2,891,000) | 342,000 | 456,000 | | Interest Expense | 159,000 | 143,000 | 141,000 | 190,000 | | Income Before Tax | (212,000) | (3,034,000) | 201,000 | 266,000 | | Income Tax Expense | (11,000) | (90,000) | 73,000 | 104,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (201,000) | (2,944,000) | 128,000 | 162,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (201,000) | (2,944,000) | 128,000 | 162,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($201,000) | ($2,944,000) | $128,000 | $162,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
